谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 2, Multicenter, Open-Label Study of Anti-Lag-3 Ieramilimab in Combination with Anti-Pd-1 Spartalizumab in Patients with Advanced Solid Malignancies

Chia-Chi Lin,Elena Garralda,Patrick Schoeffski,David S. Hong,Lillian L. Siu,Miguel Martin,Michela Maur,Rina Hui,Ross A. Soo,Joanne Chiu,Tian Zhang,Brigette Ma,Chrisann Kyi,Daniel S. W. Tan,Philippe A. Cassier,John Sarantopoulos,Andrew Weickhardt,Richard D. Carvajal,Jennifer Spratlin,Taito Esaki,Frederic Rolland,Wallace Akerley,Barbara Deschler-Baier,Lawrence Rispoli,Tanay S. Samant,Niladri Roy Chowdhury,Daniel Gusenleitner,Eunice L. Kwak,Vasileios Askoxylakis,Filippo De Braud

ONCOIMMUNOLOGY（2024）

引用 4|浏览74
关键词
Efficacy,ieramilimab,LAG-3 inhibitor,safety,spartalizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要